In a recent study published in Fertility and Sterility, researchers Amelie Stenqvist and colleagues have shed light on an intriguing aspect of male fertility and its influence on maternal health outcomes. The study, titled “High sperm deoxyribonucleic acid fragmentation index is associated with an increased risk of preeclampsia following assisted reproduction treatment,” reveals that men with high levels of sperm DNA fragmentation are more likely to contribute to an increased risk of preeclampsia in pregnancies conceived through assisted reproductive technologies (ART). This finding opens up new considerations for fertility specialists and couples pursuing ART, underscoring the male factor’s influence on pregnancy health.
Understanding Sperm DNA Fragmentation Index (DFI)
Sperm DNA fragmentation refers to breaks or lesions in the DNA of sperm cells, which can impact their quality and functionality. In this study, researchers measured the DNA fragmentation index (DFI) of sperm used in ART, finding that a high DFI was correlated with a significant increase in the incidence of preeclampsia among expectant mothers. As preeclampsia is a serious pregnancy complication involving high blood pressure and potentially leading to severe outcomes for both mother and child, identifying contributing factors is essential for managing risks.
Patient Profile and Study Design
The study analyzed data from approximately 1,200 couplesundergoing ART at fertility clinics. These patients presented with various fertility challenges and were using ART techniques such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) to achieve pregnancy. The researchers collected sperm samples from male participants, measuring their DNA fragmentation index (DFI) using the Sperm Chromatin Structure Assay (SCSA), a test known for its precision and reliability in detecting DNA fragmentation. This division of patients into high and low DFI groups allowed the team to assess the influence of DNA damage in sperm on maternal health outcomes, specifically preeclampsia risk.
Key Characteristics of Study Participants
The couples included in the study represented a broad cross-section of ART patients. Women in the study may have had underlying conditions impacting fertility, such as polycystic ovary syndrome (PCOS), endometriosis, or advanced maternal age. Male partners faced various fertility issues, including low sperm count, reduced motility, and high DNA fragmentation. This diverse sample makes the findings broadly relevant to many individuals undergoing ART.
The Link Between High Sperm DFI and Preeclampsia
By focusing on ART patients and categorizing them based on DFI levels measured by SCSA, the researchers observed that higher DFI levels were associated with an increased likelihood of preeclampsia. This association suggests that damaged sperm DNA may affect not only conception chances but also pregnancy health, possibly through epigenetic impacts on placental formation and function.
Implications for Assisted Reproduction and Fertility Clinics
For fertility specialists, these findings highlight the importance of assessing sperm quality beyond standard parameters such as count and motility. Incorporating DFI testing could provide a more comprehensive fertility profile for men, potentially helping clinics manage ART pregnancies with a better understanding of potential maternal risks. Fertility clinics might consider including DFI testing as part of ART protocols, particularly for couples with repeated ART failures or a history of preeclampsia.
Types of DFI Testing and Clinical Implications
There are several methods to measure DNA fragmentation in sperm, each with unique considerations for clinicians. While the SCSA was used in this study, other common types of DFI testing include:
- TUNEL Assay (Terminal deoxynucleotidyl transferase dUTP nick end labeling): This assay detects breaks in DNA strands by labeling fragmented DNA. TUNEL is highly sensitive and widely used but can be relatively costly and time-consuming. For clinicians, TUNEL provides an accurate measure of DNA damage and may be ideal for comprehensive fertility assessments.
- COMET Assay: The COMET assay measures DNA fragmentation by observing DNA migration patterns in an electric field, resembling a comet’s tail. It’s a sensitive and versatile test but is less standardized and can be challenging to interpret, requiring a skilled technician. This test may be best suited for specialized fertility clinics with the necessary equipment and trained staff.
- SCD (Sperm Chromatin Dispersion) Test: Also known as the Halo test, the SCD test identifies DNA fragmentation by observing the dispersion pattern of sperm chromatin. It’s simpler and more affordable than some other tests, making it accessible for broader clinical use. However, it may be less sensitive, so it might be best used as an initial screen rather than a definitive measure.
Each of these tests has strengths and limitations, so clinicians must consider factors such as cost, accessibility, sensitivity, and the specific needs of each patient. Offering a variety of DFI tests may allow clinics to tailor assessments to individual cases, balancing accuracy with feasibility.
Implications for Patients Attempting Natural Pregnancy
These findings aren’t only relevant for those pursuing ART but also for couples attempting to conceive naturally. While DNA fragmentation is not typically a standard part of fertility evaluation for natural conception, high DFI levels could impact both conception and pregnancy health. For couples who have experienced recurrent pregnancy loss, unexplained infertility, or complications in prior pregnancies, discussing DFI testing with a healthcare provider could be beneficial. A high DFI may prompt lifestyle changes or interventions aimed at reducing DNA damage, such as antioxidant therapy, lifestyle modifications, or addressing potential sources of oxidative stress, which is a known contributor to DNA fragmentation in sperm.
Additionally, this study highlights the importance of the male partner’s role in pregnancy health, urging couples to view fertility as a shared responsibility. By addressing sperm quality, men can contribute more actively to healthier pregnancies, possibly reducing the risk of complications like preeclampsia even in natural conception.
The Future of Sperm Quality Research and ART
This study opens doors for further research into sperm DNA integrity and its broader impact on reproductive health. As we learn more about the role of male fertility factors, it becomes clear that male contributions to conception extend beyond fertilization alone. Improving sperm quality could not only enhance conception rates but also contribute to safer, healthier pregnancies—especially those achieved through ART.
In summary, this association between high sperm DNA fragmentation and an increased preeclampsia risk highlights a deeper role for sperm quality in reproductive outcomes. The findings emphasize the importance of thorough male fertility assessments in ART, potentially leading to better-informed treatment plans and healthier pregnancies for couples navigating infertility challenges. For couples attempting natural conception, understanding and potentially addressing DFI could also support healthier pregnancies and help mitigate pregnancy risks.
Reference:
- Amelie Stenqvist, Mona Bungum, Anja Bisgaard Pinborg, Jeanette Bogstad, Anne Lis Englund, Marie Louise Grøndahl, Anne Zedeler, Stefan R. Hansson, Aleksander Giwercman. High sperm deoxyribonucleic acid fragmentation index is associated with an increased risk of preeclampsia following assisted reproduction treatment. Fertility and Sterility, 2024; DOI: 10.1016/j.fertnstert.2024.08.316
Dr Marina OBGYN